Skip to main content

Table 1 Patient characteristics

From: Intermediate-term outcome after PSMA-PET guided high-dose radiotherapy of recurrent high-risk prostate cancer patients

Salvage Radiotherapy (SRT) n = 22

PSA before surgery (ng/ml)

18.9 (3.14–115) Avg. (range)

Postoperative Gleason score

8 (6–10) Avg. (range)

PSA before SRT

6.1 (0.2–34.5) Avg. (range)

Months between surgery and SRT

29 (2–201) Avg. (range)

Concomitant androgen deprivation

10 of 22

Postoperative T stage

 T 2

7

 T 3

14

 T 4

1

Surgical margin status

 R 0

10

 R 1

11

 R 2

1

Postoperative PSA values

 PSA < 0.1 ng/ml

23

 PSA > 0.1 ng/ml

9